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1341arteries and aorta in regions with and without plaque,
providing a target-to-background ratio (TBR) as the
ratio of maximal/mean arterial wall standardized
uptake values andmean venous blood activity (3).
The included patients (4 men and 4 women; mean
age 68  6 years) had a history (>6 months) of tran-
sient ischemic attack (n ¼ 5), ischemic stroke (n ¼ 3),
and/or myocardial infarction (n ¼ 3). Patients had an
increased carotid wall thickness as shown by MRI,
providing a mean normalized wall index of 0.60 
0.07 (Figure 1). In addition, patients exhibited
enhanced FDG uptake at the level of both the carotid
arteries and aorta as assessed with PET/CT, as shown
by the increased maximal target-to-background
ratio for 18F-ﬂuorodeoxyglucose (FDGTBRmax) for the
carotid arteries (1.72  0.25) and aorta (2.61  0.64)
(Figure 1).
Subsequently, HX4 uptake was assessed at the level
of the carotid arteries in 4 patients and at the level of
the aorta in the other 4 patients (Figure 1). When
quantiﬁed, HX4TBRmax of the carotid arteries was
1.27  0.13 and 1.98  0.27 for the aorta (Figure 1). HX4
uptake was speciﬁc to plaque regions —HX4TBRmax
was 1.32  0.16 in the most diseased segment
compared with 1.15  0.20 in the nonplaque region
(p < 0.01) (Figure 1). Following the relationship
between plaque burden and hypoxia, we observed a
strong correlation between atherosclerotic HX4
uptake and carotid arterial wall dimensions (r ¼ 0.97;
p ¼ 0.04). In addition, we showed a correlation with
HX4 uptake and FDG uptake in the plaque (r ¼ 0.75;
p ¼ 0.03).
Taken together, we showed increased HX4 uptake
in plaque regions that correlated to arterial wall
dimensions and metabolic activity. Recently, a pre-
clinical PET study in atherosclerotic rabbits showed
positive correlations of the hypoxia tracer 18F-
ﬂuoromisonidazole to plaque burden and macrophage
content, but not to FDG uptake, which might
reﬂect distinct differences in rabbit and human
plaque composition (4). In support, previous work in
human carotid artery specimens showed in situ
correlations between a nonradioactive structural
analogue of HX4, pimonidazole, and features of
plaque vulnerability (5). Nonetheless, additional
studies are warranted to assess HX4’s relationship
with FDG and its direct link to hypoxia-associated
molecules in human plaques. Future studies are
aimed at: 1) using additional MRI imaging sequences
or MRI–traceable HX4 to overcome the low spatial
resolution of PET and provide greater insight in HX4
uptake in different plaque components; and 2)
addressing the relationship between HX4, hypoxia,
and plaque vulnerability in vivo.In conclusion, we present a noninvasive imaging
approach to visualize hypoxia in advanced athero-
sclerotic lesions in humans in vivo. Current data
support efforts to develop and implement imaging
modalities to quantify hypoxia in patients at risk for
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1258–65.Serial Multimodality Evaluation of
Aortocoronary Bypass Grafts During the
First Year After CABG SurgeryThe CABG-PRO (Cardiac Catheterization for Bypass
Graft Patency Rate Optimization) trial (NCT01063491),
was a randomized, controlled, double-blind, parallel-
group study of early versus no early graft angiography
in patients undergoing coronary artery bypass graft
(CABG) surgery. Enrollment in the CABG-PRO trial was
stopped early because of low rates of saphenous vein
graft (SVG) percutaneous coronary intervention
among patients undergoing early coronary angiog-
raphy (1 of 21 patients). Of those 21 patients, matched
FIGURE 1 Serial Imaging of Saphenous Vein Grafts Immediately After Coronary Bypass Graft Surgery and at Follow-Up
Serial saphenous vein graft imaging was performed using intravascular ultrasonography (A) and optical coherence tomography, demonstrating
a valve immediately after surgery (B) and demonstrating thrombus (C). Effect of local baseline endothelial shear stress (ESS) on saphenous vein
graft lumen area changes (D).
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1342baseline and 12-month follow-up angiography
and intravascular imaging was obtained for 14 -
patients, who formed the population of the present
study.
Quantitative coronary angiography measurements
were taken in 13 left internal mammary grafts, 30
SVGs, and 50 native coronary arteries that were
bypassed. During the ﬁrst year after CABG, the mini-
mal and mean SVG lumen diameter signiﬁcantly
decreased (from 2.83 0.85mm to 1.990.76mm [p<
0.0001] and from 3.94  1.16 mm to 2.78  0.92 mm
[p < 0.0001], respectively). No signiﬁcant differences
were observed in the lumen dimensions of the
left internal mammary grafts or the native coronary
arteries.
Paired intravascular ultrasound measurements
(immediately after CABG and at 12 months) were
available for 13 SVGs (Figure 1A). Signiﬁcant
decreases were observed in mean lumen diameter
(from 4.26  0.63 mm to 3.31  0.76 mm; p ¼
0.0002), lumen cross-sectional area (from 14.56 
4.58 mm2 to 9.10  4.67 mm2; p ¼ 0.0005), mean
vessel diameter (from 5.26  0.65 mm to 4.80  0.61
mm; p ¼ 0.03), and vessel cross-sectional area(from 22.08  5.68 mm2 to 18.45  4.99 mm2;
p ¼ 0.03). However, increases in SVG mean wall
thickness (from 0.50  0.09 mm to 0.74  0.17 mm;
p ¼ 0.0007) and mean wall cross-sectional area
(from 7.52  1.83 mm2 to 9.53  1.94 mm2; p ¼ 0.03)
were observed.
Optical coherence tomography (OCT) imaging
immediately after CABG and 12 months later was
available for 10 SVGs. The mean lumen diameter
decreased from 4.36  0.64 mm at baseline to 3.14 
0.85 mm at follow-up (p ¼ 0.0005), and the lumen
cross-sectional area decreased from 14.44  4.18 mm2
to 7.74  4.47 mm2 (p ¼ 0.0003). Similar to the intra-
vascular ultrasound ﬁndings, SVG dimensions were
smaller at follow-up imaging (mean vessel diameter
5.16  0.69 mm at baseline vs. 4.46  0.79 mm at
follow-up [p ¼ 0.0009]; vessel cross-sectional area
21.43  5.81 mm2 at baseline vs. 16.19  6.32 mm2
at follow-up [p ¼ 0.0016]), whereas wall thickness
signiﬁcantly increased (0.31  0.05 mm at baseline vs.
0.53  0.12 mm at follow-up; p ¼ 0.0005). SVG valves
(Figure 1B) were visualized at baseline OCT
examination in all SVGs but were fused into the
vessel wall at 12 months in all SVGs. Intraluminal
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1343thrombuswas present in 6 of 10 SVGs at baseline versus
1 of 10 SVGs at 12 months (Figure 1C). Mean thrombus
area at baseline imaging was 0.37  0.28 mm2. A
double-layer appearance was identiﬁed by OCT
imaging in the wall of all studied SVGs at the 12-
month follow-up. The median thickness of the inner
layer was 0.23 mm (interquartile range: 0.20 to 0.28
mm), and its area was 3.73 mm2 (interquartile range:
2.79 to 4.92 mm2), representing 25% (interquartile
range: 22% to 29%) of the total vessel cross-sectional
area.
Three-dimensional (3D) SVG reconstruction was
performed using a previously validated method-
ology on the basis of the 3D luminal centerline
derived from angiographic projections (1,2). The ob-
tained 3D lumen reconstructions were then used for
assessing the local endothelial shear stress (ESS) dis-
tribution by employing computational ﬂuid dy-
namics, as previously described (3). Baseline low ESS
was associated with: 1) the largest decrease in lumen
area (p < 0.001 vs. moderate and high ESS); 2) the
largest increase in plaque burden (p ¼ 0.011 vs. high
ESS); and 3) augmented ﬁbrous neointimal area, as
represented by the inner wall layer area at follow-up
(p ¼ 0.020 vs. moderate ESS and p ¼ 0.009 vs. high
ESS) (Figure 1D).
In summary, during the ﬁrst year after CABG, SVGs
undergo signiﬁcant lumen loss due to a combination
of wall thickening and negative remodeling. SVG
segments with the lowest ESS develop the largest
negative remodeling and neointima formation. These
ﬁndings provide important insights into the patho-
genesis of early SVG failure.Anna P. Kotsia, MD
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culation 2012;126:172–81.3D Transthoracic Echocardiography Provides
Accurate Cross-Sectional Area of the RV
Outﬂow TractMeasurement of the cross-sectional area (CSA) of the
right ventricular outﬂow tract (RVOT) has been
required to calculate stroke volume, especially for
estimation of the pulmonary blood ﬂow/systemic
blood ﬂow ratio. Current guidelines of the American
Society of Echocardiography state that the CSA should
be calculated using the RVOT diameter measured in
either the parasternal long-axis view or parasternal
short-axis view. Recently, the shape of the RVOT has
been reported to be oval when using 3-dimensional
(3D) transesophageal echocardiography (1); however,
the dynamic change of RVOT geometry in a cardiac
cycle has not been well validated with any
modality. The aim of this study was to assess
morphological and dynamic features of the RVOT
using multidetector computed tomography (MDCT)
and to compare the CSA of the RVOT obtained by
MDCT and by 3D or 2-dimensional (2D) transthoracic
echocardiography (TTE).
A total of 20 patients with clinically indicated
contrast MDCT were prospectively enrolled between
May and September 2014 at Tokushima University
Hospital. This study was conducted in accordance
with the Declaration of Helsinki, was approved by the
Institutional Review Board of the University of
Tokushima, and each subject gave written informed
consent. The MDCT examination was performed
using a 320-MDCT scanner (Aquilion ONE, Toshiba
Medical Systems, Tokyo, Japan). Retrospective
